Thrombosis Events May Be Clarified By e-CYPHER Data Expected In February
This article was originally published in The Gray Sheet
Executive Summary
FDA's public health notification related to adverse events for J&J/Cordis' Cypher is intended to generate further data collection for the drug-eluting stent rather than raise undue concern over clotting issues, the agency says